| Literature DB >> 33441501 |
Kumiko Takeda1, Eiji Kobayashi1, Kazuko Ogata1, Akira Imai2, Shinya Sato2, Hiromichi Adachi3, Yoichiro Hoshino4, Kagetomo Nishino5, Masahiro Inoue6, Masahiro Kaneda7, Shinya Watanabe1,8.
Abstract
For semen suppliers, predicting the low fertility of service bull candidates before artificial insemination would help prevent economic loss; however, predicting bull fertility through in vitro assessment of semen is yet to be established. In the present study, we focused on the methylated CpG sites of sperm nuclear DNA and examined methylation levels to screen new biomarkers for predicting bull fertility. In frozen-thawed semen samples collected from Japanese Black bulls, for which the sire conception rate (SCR) was recorded, the methylation level of each CpG site was analyzed using human methylation microarray. According to regression analysis, 143 CpG sites related to SCR were significantly differentially methylated. Whole genome bisulfite sequence data were obtained from three semen samples and the differentially methylated regions (DMRs) that included the target CpG sites selected by human methylation microarray were confirmed. Using combined bisulfite restriction analysis, fertility-related methylation changes were detected in 10 DMRs. With the exception of one DMR, the methylation levels of these DMRs were significantly different between groups with high fertility (> 50%) and low fertility (< 40%). From multiple regression analysis of methylation levels and SCR, three DMRs were selected that could effectively predict bull fertility. We suggest that these fertility-related differences in spermatozoal methylation levels could be new epigenetic biomarkers for predicting bull fertility.Entities:
Keywords: Bull; DNA methylation; Fertility; Microarray; Spermatozoa
Mesh:
Substances:
Year: 2021 PMID: 33441501 PMCID: PMC8075730 DOI: 10.1262/jrd.2020-137
Source DB: PubMed Journal: J Reprod Dev ISSN: 0916-8818 Impact factor: 2.214
Fig. 1.Sire conception rate (SCR, %) and age (in months) of each semen sample used for EPIC microarray analysis (A: n = 17 from 14 bulls) and combined bisulfite restriction analysis (COBRA; B: n = 50 from 28 bulls). Samples were divided into high fertility (HF: > 50% fertility) and low fertility (LF: < 40% fertility) groups. The LF samples categorized in the LF1 cluster by EPIC (see Fig. 2C) are shown as white squares; the LF sample that was categorized in the HF cluster by EPIC (see Fig. 2C) is shown as an asterisk.
Fig. 2.Heatmaps (A and B) showing the different methylation levels analyzed by EPIC microarray at (A) 332 selected CpG sites that differed between high fertility (HF, n = 6) and low fertility (LF, n = 7) sample groups and (B) 143 differential CpG sites selected according to regression analysis using a linear model of each CpG site in 17 samples with sire conception rate data. The dendrograms above and to the left of the heatmaps show hierarchical clustering results among individual animals and among the CpG sites based on the methylation data, respectively. The gray scale at the upper left of each heatmap indicates methylation status, with white (0.0) being the lowest and black (1.0) being the highest methylation level. A cluster analysis (C) was also conducted using the methylation levels of the 143 CpGs shown in B. The LF sample categorized into the HF cluster is shown by an asterisk.
Primers and locations of target CpGs revealed by combined bisulfite restriction analysis (COBRA)
| ID | Forward and reverse primer sequences | Product length (bp) | Annealing (°C) | Restriction enzyme | No. of restriction sites | Restriction fragment length a (bp) | CpG location (chromosome no.) | Features | Target ID of EPIC |
|---|---|---|---|---|---|---|---|---|---|
| CpG-F1 | 5'TAAATGGTTTTAGTAAGAAATTAAATATAA3' | 196 | 50 | HpyCH4IV | 2 | 160, 28, 8 | NC_037353.1, 38105097 (26) | 5': empty spiracles homeobox 2 | cg13647079 |
| 5'CCAACTAAACAAATCATTATAAAACTA3' | 3': RAB11 family interacting protein 2 | ||||||||
| CpG-F2 | 5'GGTTTTGTGTGGTTGTATAGTGAAT3' | 188 | 50 | BstUI | 1 | 141, 47 | NC_037334.1, 11271815 (7) | DnaJ heat shock protein family (Hsp40) member B1 | cg07483523 |
| 5'AAATCCTTTCAAAAAAAATCACTTC3' | |||||||||
| CpG-F3 | 5'GGGTATTGGGGAGATATTTTTGTAT3' | 180 | 54 | TaqI | 2 | 110, 35, 35 | NC_037350.1, 27193986 (23) | Neurogenic locus notch homolog protein 4 isoform X1neurogenic locus notch homolog protein 4 precursor | cg08801479 |
| 5'CAACCCCAATATACACTAACCTAACA3' | |||||||||
| CpG-F4 | 5'GAAAATGTGGGAAAATTTATATTTTTG3' | 283 | 56 | BstUI | 1 | 165, 118 | NC_037350.1, 22717962 (23) | - | cg23797553 |
| 5'ATCAACCATCCATCCATCTAATTAA3' | |||||||||
| CpG-F5 | 5'TAGAGAGGTTATTTGGGAGGTATTT3' | 215 | 52 | TaqI | 1 | 139,76 | NC_037348.1, 65954056 (21) | 5' side: retrotransposon-like protein 1 | cg05537796 |
| 5'CCCTTCAAATACCAAAAAAAATACTAA3' | 3' side: thyroxine 5-deiodinase | ||||||||
| CpG-F6 | 5'TGTTTTTTTGGTATGGTTTTTTGTT3' | 228 | 50 | AciI | 1 | 151, 77 | NC_037343.1, 4869926 (16) | Ubiquitin thioesterase OTU1 | cg07483523 |
| 5'AACATCCACTATAATCCACTTCATCTTAT3' | |||||||||
| CpG-F7 | 5'GGGGGTTTAGTTTTTTAGTTTTTTAAAT3' | 136 | 56 | TaqI | 1 | 100, 36 | NC_037353.1, 24169514 (26) | SH3 and PX domain-containing protein 2A isoform X2SH3 and PX domain-containing protein 2A isoform X3 | cg04762698 |
| 5'CACCACATACAATACCTACCAAAAA3' | |||||||||
| CpG-F8 | 5'GTGGAGTTTGGGTTATTTATTTTTG3' | 213 | 57 | TaqI | 1 | 162, 51 | NC_037350.1, 7490261 (23) | Death domain associated protein | cg27584448 |
| 5'CACCACCTCTAATAAACCCTCTAAA3' | |||||||||
| CpG-F9 | 5'TTTTGTAGGTAGGAAGTTGGATTGT3' | 290 | 52 | HpyCH4IV | 1 | 227, 63 | NC_037338.1, 10665097 (11) | Methylcytosine dioxygenase TET3 isoform X1 | cg17184593 |
| 5'CAACTAATACAAACCCCACAATTTT3' | |||||||||
| CpG-F10 | 5'TGAATAGTAGTTGAATATGGGTTAGT3' | 236 | 50 | AciI | 3 | 134, 102 | NC_037333.1, 109018628 (6) | 5' side: biorientation of chromosomes in cell division 1 3' side: cytoplasmic polyadenylation element binding protein 2 | cg05696584 |
| 5'CCCTACCCTTCACAAAAAAAA3' | |||||||||
a) Restriction fragment length when all CpGs located in restriction endonuclease cleavage sites are methylated.
Fig. 3.The methylation differences of peripheral regions (4 kbps) containing the target CpG sites revealed by whole genome bisulfite sequencing results (n = 3; L5-1, L7, and H7-1). The peripheral areas of CpG-F1, -F3, -F4, -F5, -F8, and -F9 are shown. Arrows indicate target CpG sites identified by EPIC microarray analysis.
Effectiveness of candidate fertility-associated–differential methylation regions (cFA-DMRs) revealed by significant differences (P < 0.05) between methylation levels and sire conception rate (SCR, %) or between fertility groups [high fertility (HF) vs. low fertility (LF)]
| EPIC | COBRA | |||||
|---|---|---|---|---|---|---|
| ID | SCR a | HF vs. LF c | SCR a | HF vs. LF c | Age a | SCR-Age a,b |
| CpG-F1 | 0.578 | 0.447 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
| CpG-F2 | 0.007 | 0.013 | < 0.001 | < 0.001 | < 0.001 | 0.001 |
| CpG-F3 | 0.018 | 0.010 | < 0.001 | < 0.001 | 0.036 | < 0.001 |
| CpG-F4 | 0.054 | 0.103 | 0.004 | 0.031 | < 0.001 | 0.040 |
| CpG-F5 | 0.002 | 0.009 | < 0.001 | 0.008 | < 0.001 | 0.002 |
| CpG-F6 | 0.005 | 0.043 | 0.017 | 0.051 | < 0.001 | 0.195 |
| CpG-F7 | 0.080 | 0.118 | 0.015 | 0.028 | 0.012 | 0.102 |
| CpG-F8 | 0.013 | 0.016 | < 0.001 | 0.002 | < 0.001 | 0.002 |
| CpG-F9 | 0.008 | 0.004 | 0.002 | < 0.001 | < 0.001 | 0.036 |
| CpG-F10 | 0.005 | 0.015 | 0.002 | < 0.001 | 0.004 | 0.023 |
Results of EPIC microarray analysis and combined bisulfite restriction analysis (COBRA) are shown. a) For SCR, Age, and SCR-Age, differences were analyzed by linear regression. b) For SCR-Age, linear regression analysis was performed while considering the effect of age. c) For HF vs. LF, differences between the HF and LF groups were analyzed using a Mann-Whitney U test.
Fig. 4.Fertility-related methylation changes identified as candidate fertility-associated–differential methylation regions (cFA-DMRs; i.e., CpG-F3–F5) according to combined bisulfite restriction analysis (COBRA). Upper panels: according to linear regression analysis, the correlations between the methylation level of each DMR and the sire conception rate (SCR, %) of the sample were statistically significant (P < 0.01, n = 50). The equation and R2 value from the analyses have been reported with each graph. Lower panels: significant differences were observed between the methylation levels of the high fertility (HF, n = 21) and low fertility (LF, n = 20) groups (Mann-Whitney U test, * P < 0.05, ** P < 0.01).
Fig. 5.The predicted sire conception rate (SCR, %) for 50 samples calculated using multiple regression equations with the methylation levels of 10 candidate fertility-associated–differential methylation regions (cFA-DMRs; left panel) and three selected cFA-DMRs (CpG-F3–F5; right panel). Correlations between the actual and predicted SCRs produced coefficients of 0.71 and 0.67 for the 10 and 3 cFA-DMR analyses, respectively. The equation and R2 value from the analyses are reported with each graph.